Compare / Grow Therapy vs Zoom
AT A GLANCE
FUNDING HISTORY
Grow Therapy
Zoom
BUSINESS MODEL
Grow Therapy
Two-sided marketplace for mental health. Therapists join Grow Therapy's network and the company handles insurance credentialing, claims billing, scheduling, and compliance.
In return, Grow Therapy takes a percentage of each session's insurance reimbursement. Patients search Grow Therapy's directory to find in-network therapists by specialty, insurance plan, and availability.
The therapist gets to focus on therapy. The patient gets affordable care.
Grow Therapy gets a cut for handling the business side. Everyone wins except the old credentialing companies that charged therapists thousands of dollars to do what Grow Therapy does for free.
Zoom
Zoom uses a freemium model. Free accounts get unlimited one-on-one meetings and 40-minute group meetings.
Paid plans start at $13.33/month per user for Pro (meetings up to 30 hours), $18.33/month for Business, and custom pricing for Enterprise. Zoom also charges for add-ons — Zoom Phone (cloud phone system), Zoom Rooms (conference room hardware), and Zoom Contact Center.
The free tier is the hook. The 40-minute limit on group calls creates just enough friction to push power users to pay.
And once one person in a company pays, the whole team follows because nobody wants to be the one whose meetings keep getting cut off.
HOW THEY STARTED
Grow Therapy
Jake Cooper was working in healthcare operations when he saw the same problem from both sides. Patients couldn't find therapists who accepted their insurance.
Therapists wanted to accept insurance but the credentialing process took 6 to 12 months and the billing was a bureaucratic disaster. Most therapists just went cash-pay to avoid the headache, which meant only people who could afford $200 a session got care.
Cooper started Grow Therapy in 2020 to solve the plumbing problem. Not the clinical side — the administrative infrastructure that makes it possible for a therapist to see an insured patient without losing their mind.
He launched right as the pandemic made therapy demand explode and supply couldn't keep up.
Zoom
Eric Yuan grew up in Tai'an, a mining city in Shandong province, China. In the mid-1990s he was in his twenties and inspired by the internet boom happening in America.
He applied for a US visa. He was rejected.
He applied again. Rejected again.
Eight times in total over about two years before he was finally approved in 1997. He moved to Silicon Valley with barely any English and joined WebEx as one of its first engineers.
Yuan spent 14 years at WebEx, eventually becoming VP of Engineering. Cisco acquired WebEx in 2007 for $3.2 billion.
Yuan watched Cisco slowly bloat the product with enterprise features while the core video quality deteriorated. He kept telling Cisco leadership they needed to rebuild the product from scratch.
They kept saying no.
In 2011, Yuan quit and took 40 WebEx engineers with him. He founded Zoom Video Communications with a simple thesis: video meetings should just work.
No downloads. No lag.
No "can you hear me?" No IT department required. He built the product that Cisco refused to build.
HOW THEY GREW
Grow Therapy
Supply-side acquisition — recruit therapists by solving their biggest pain point (insurance credentialing) for free. Once therapists are in-network through Grow Therapy, patients find them through the directory.
The company expanded insurance partnerships aggressively, getting in-network with Aetna, Cigna, UnitedHealthcare, Anthem, and dozens of regional plans. State-by-state expansion tracking licensing requirements.
Content marketing targeting therapists frustrated with private practice admin. Referral loops from satisfied therapists bringing colleagues onto the platform.
Zoom
Zoom grew on one thing: it worked. In a world where every video call started with five minutes of technical issues, Zoom calls just connected.
That reliability was the entire marketing strategy for the first five years.
The freemium model did the rest. Teachers, coaches, therapists, book clubs, and small teams all started on the free tier.
When they hit the 40-minute limit, enough of them converted to paid. And every free meeting was essentially a demo — everyone in the meeting saw how good Zoom was.
Yuan obsessed over simplicity. While competitors like WebEx and GoToMeeting required downloads, plugins, and IT involvement, Zoom worked in the browser with one click.
The learning curve was essentially zero. Your grandmother could figure it out.
That turned out to be extremely important when a pandemic suddenly required your grandmother to figure it out.
Then COVID happened. In March 2020, the world shut down.
Every meeting — work, school, family, doctor, church, happy hour — moved to video. Zoom was already the easiest option.
Daily participants exploded from 10 million to 300 million in four months. The stock went from $70 to $588.
THE HARD PART
Grow Therapy
Insurance reimbursement rates for therapy are low and getting lower in some states. Grow Therapy's margin depends on volume because per-session economics are thin.
Keeping therapists on the platform once they're credentialed is a retention challenge — some therapists use Grow Therapy to get credentialed, then leave to handle billing themselves. Competition from Headway, Alma, and others doing similar things means the race to sign up therapists is intense.
Quality control across 10,000+ providers is a real concern. And the fundamental tension remains: insurance companies want to pay less per session, therapists need to earn enough to survive, and Grow Therapy sits in the middle trying to make both sides happy.
Zoom
The post-pandemic hangover has been severe. Zoom's stock peaked at $588 in October 2020 and crashed to under $70 by 2022 — an 88% drop.
The company went from the most exciting tech stock on the planet to a cautionary tale about pandemic valuations. Revenue growth slowed from 300%+ to single digits as people returned to offices and competitors caught up.
Security and "Zoombombing" were early crises. In early 2020, as millions of new users flooded in, trolls discovered they could join open Zoom meetings and share offensive content.
Schools, churches, and AA meetings were disrupted. It turned out Zoom's encryption wasn't truly end-to-end as advertised.
Yuan had to halt all feature development for 90 days and focus exclusively on security fixes. It was a near-death reputational crisis.
Competition from Microsoft Teams and Google Meet intensified. Both companies bundled video calling for free into products that hundreds of millions of people already used.
Microsoft Teams integrated directly into Office 365. Google Meet was built into Gmail.
Zoom had to compete against free products from two of the richest companies on Earth.
THE PRODUCTS
Grow Therapy
Insurance credentialing — gets therapists paneled with major insurers in weeks instead of months. Automated billing and claims processing that eliminates the denied-claim nightmare.
A patient-facing directory with filters for insurance, specialty, location, and availability. Practice management tools including scheduling, intake forms, and session notes.
Telehealth platform built in so therapists don't need separate video software. Group practice support for therapists who want to scale beyond solo practice.
Zoom
Zoom Meetings is the core — video calls that actually work. Zoom Webinars handles large-scale events with up to 50,000 attendees.
Zoom Phone is a full cloud-based phone system replacing traditional office phones. Zoom Rooms turns physical conference rooms into one-click video meeting spaces.
Zoom Contact Center competes with established call center software. Zoom Team Chat is their Slack/Teams competitor.
Zoom Whiteboard is a collaborative digital canvas. Zoom Revenue Accelerator uses AI to analyze sales calls.
And Zoom AI Companion summarizes meetings and drafts messages.
WHO BACKED THEM
Grow Therapy
Investors include Sequoia Capital, TCV, Signalfire, and SVB Capital. Series C in 2023 valued the company at over $1 billion.
Zoom
Sequoia Capital, Emergence Capital, Horizons Ventures (Li Ka-shing), Qualcomm Ventures